EDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT
/PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced that one-year results on patients treated in the single-arm, prospective, global,...
Stay updated with breaking news from Niklas Schofer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced that one-year results on patients treated in the single-arm, prospective, global,...
/PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced that one-year results on patients treated in the single-arm, prospective, global,...
Pi-Cardia announced today that it completed a successful first-in-human treatment of the mitral valve with its ShortCut device.
DGAP-News: Pi-Cardia Ltd. / Key word(s): Miscellaneous Pi-Cardia Successfully Performs Mitral Valve Splitting With ShortCut™ 22.08.2022 / 15:00 CET/CEST The issuer is solely responsible for the content of this announcement. Pi-Cardia Successfully Performs Mitral Valve Splitting with ShortCut™ Fi...